Lincoln [LINCOLN] vs Divi's Laboratories [DIVISLAB] Detailed Stock Comparison

Lincoln

NSE
Loading...

Divi's Laboratories

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Lincoln wins in 7 metrics, Divi's Laboratories wins in 13 metrics, with 0 ties. Divi's Laboratories appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricLincolnDivi's LaboratoriesBetter
P/E Ratio (TTM)12.3565.37Lincoln
Price-to-Book Ratio1.5910.13Lincoln
Debt-to-Equity Ratio0.000.03Lincoln
PEG Ratio0.732.47Lincoln
EV/EBITDA8.4448.31Lincoln
Profit Margin (TTM)13.71%23.89%Divi's Laboratories
Operating Margin (TTM)13.19%25.60%Divi's Laboratories
EBITDA Margin (TTM)13.19%25.60%Divi's Laboratories
Return on Equity12.26%14.64%Divi's Laboratories
Return on Assets (TTM)10.33%12.94%Divi's Laboratories
Free Cash Flow (TTM)$737.71M$2.15BDivi's Laboratories
Dividend Yield0.32%0.91%Divi's Laboratories
1-Year Return-19.68%8.12%Divi's Laboratories
Price-to-Sales Ratio (TTM)1.6915.71Lincoln
Enterprise Value$8.69B$1,480.60BDivi's Laboratories
EV/Revenue Ratio1.3815.34Lincoln
Gross Profit Margin (TTM)54.96%60.33%Divi's Laboratories
Revenue per Share (TTM)$315$363Divi's Laboratories
Earnings per Share (Diluted)$43.09$87.36Divi's Laboratories
Beta (Stock Volatility)0.190.18Divi's Laboratories
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Lincoln vs Divi's Laboratories Stock Performance Analysis

Loading Price Chart...

Lincoln
Divi's Laboratories
Lincoln Stock Overview | Divi's Laboratories Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Lincoln0.11%-0.88%-4.12%-4.76%-7.24%-37.86%
Divi's Laboratories2.73%3.10%-4.83%-14.69%1.79%-3.41%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Lincoln-19.68%82.29%118.12%147.47%147.47%147.47%
Divi's Laboratories8.12%57.02%83.89%435.51%1,516.65%7,132.15%

News Based Sentiment: Lincoln vs Divi's Laboratories

Lincoln

News based Sentiment: MIXED

September presented a mixed bag for Lincoln Pharmaceuticals, with a concerning revenue decline in Q3 offset by a strong Q1 FY26 performance. The conflicting signals from analysts and declining investor interest create a complex investment picture, making this a significant month for understanding the company's trajectory.

View Lincoln News Sentiment Analysis

Divi's Laboratories

News based Sentiment: MIXED

September presented a mixed bag for Divi's Laboratories, with stellar FY25 results overshadowed by a weaker Q1 FY26 performance and fluctuating analyst opinions. The Nifty 50 exclusion adds another layer of complexity, creating a dynamic investment scenario that requires careful monitoring.

View Divi's Laboratories News Sentiment Analysis

Performance & Financial Health Analysis: Lincoln vs Divi's Laboratories

MetricLINCOLNDIVISLAB
Market Information
Market Cap i₹10.67B₹1.61T
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i18,016437,716
90 Day Avg. Volume i23,230381,180
Last Close₹532.55₹5,866.00
52 Week Range₹499.00 - ₹979.50₹4,955.00 - ₹7,071.50
% from 52W High-45.63%-17.05%
All-Time High₹979.50 (Dec 09, 2024)₹7,071.50 (Jul 08, 2025)
% from All-Time High-45.63%-17.05%
Growth Metrics
Quarterly Revenue Growth0.05%0.14%
Quarterly Earnings Growth0.17%0.27%
Financial Health
Profit Margin (TTM) i0.14%0.24%
Operating Margin (TTM) i0.13%0.26%
Return on Equity (TTM) i0.12%0.15%
Debt to Equity (MRQ) i0.000.03
Cash & Liquidity
Book Value per Share (MRQ)₹335.40₹563.87
Cash per Share (MRQ)₹97.95₹132.86
Operating Cash Flow (TTM) i₹967.87M₹19.67B
Levered Free Cash Flow (TTM) i₹823.46M₹21.91B
Dividends
Last 12-Month Dividend Yield i0.32%0.91%
Last 12-Month Dividend i₹1.80₹60.00

Valuation & Enterprise Metrics Analysis: Lincoln vs Divi's Laboratories

MetricLINCOLNDIVISLAB
Price Ratios
P/E Ratio (TTM) i12.3565.37
Forward P/E iN/A101.43
PEG Ratio i0.732.47
Price to Sales (TTM) i1.6915.71
Price to Book (MRQ) i1.5910.13
Market Capitalization
Market Capitalization i₹10.67B₹1.61T
Enterprise Value i₹8.69B₹1.48T
Enterprise Value Metrics
Enterprise to Revenue i1.3815.34
Enterprise to EBITDA i8.4448.31
Risk & Other Metrics
Beta i0.190.18
Book Value per Share (MRQ) i₹335.40₹563.87

Financial Statements Comparison: Lincoln vs Divi's Laboratories

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)LINCOLNDIVISLAB
Revenue/Sales i₹1.54B₹24.10B
Cost of Goods Sold i₹693.84M₹9.56B
Gross Profit i₹846.82M₹14.54B
Research & Development iN/AN/A
Operating Income (EBIT) i₹203.27M₹6.17B
EBITDA i₹390.76M₹8.48B
Pre-Tax Income i₹353.89M₹7.33B
Income Tax i₹77.14M₹1.88B
Net Income (Profit) i₹276.75M₹5.45B

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)LINCOLNDIVISLAB
Cash & Equivalents i₹134.14M₹4.15B
Total Current Assets i₹5.00B₹100.81B
Total Current Liabilities i₹1.06B₹14.52B
Long-Term Debt iN/A₹20.00M
Total Shareholders Equity i₹6.72B₹149.69B
Retained Earnings i₹5.86B₹134.00B
Property, Plant & Equipment i₹220.84M₹3.19B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)LINCOLNDIVISLAB
Operating Cash Flow iN/AN/A
Capital Expenditures iN/AN/A
Free Cash Flow iN/AN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricLINCOLNDIVISLAB
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i18,016437,716
Average Daily Volume (90 Day) i23,230381,180
Shares Outstanding i20.03M265.47M
Float Shares i8.79M120.77M
% Held by Insiders i0.55%0.52%
% Held by Institutions i0.01%0.29%

Dividend Analysis & Yield Comparison: Lincoln vs Divi's Laboratories

MetricLINCOLNDIVISLAB
Last 12-Month Dividend i₹1.80₹60.00
Last 12-Month Dividend Yield i0.32%0.91%
3-Year Avg Annual Dividend i₹1.70₹50.00
3-Year Avg Dividend Yield i0.29%0.70%
3-Year Total Dividends i₹5.10₹150.00
Ex-Dividend DateSep 12, 2025Jul 25, 2025